PAVmed PAVM 深 滬
等待開盤 09-17 09:30:00 美东时间
3.92
0.000
0.00%
華盛通- 最 高4.2233
- 今 開4.05
- 成交量 4.79万股
- 最 低 3.92
- 昨 收 3.92
- 總市值 3858.33万
- 52周最高 28.44
- 市盈率 靜 --
- 換手率 0.49%
- 52周最低 3.70
- 委 比 50.00%
- 總股本 984.27万
- 歷史最高 6841.5963
- 量 比 1.78
- 振 幅 7.74%
- 歷史最低 3.70
- 每 手 1
- 風險率 2.95%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PAVmed Launches New At-the-Market Equity Offering
PAVmed ( ($PAVM) ) has provided an update. On September 9, 2026, PAVmed Inc. en...
09-10 18:35
美股前瞻 | 聚焦今夜22点！沃什杰克逊霍尔首秀或“释放重磅信号”；Anthropic最快九月下旬美股上市；迈威尔科技绩后暴跌8%
聚焦今夜22点！沃什杰克逊霍尔首秀或“释放重磅信号”；Anthropic拟募资1300亿美元！最快九月下旬美股上市；迈威尔科技绩后重挫8%，财报强劲市场仍“不买账”>>
08-28 20:31
美股大行评级 | 潜在涨幅1024.26%！Ascendiant Capital上调PAVmed目标价至57美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从56美元升至57美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9.25美元升至9.5美元
08-28 16:15
Nvidia To Rally Around 146%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Evercore ISI Group raised the price target for Salesforce Inc (NYSE:CRM) from $250 to $290. Evercore ISI Group...
08-27 21:19
Ascendiant Capital Maintains Buy on PAVmed, Raises Price Target to $57
Ascendiant Capital analyst Edward Woo maintains PAVmed (NASDAQ:PAVM) with a Buy and raises the price target from $56 to $57.
08-27 19:40
PAVmed GAAP EPS of $0.87
PAVmed press release (PAVM): Q2 GAAP EPS of $0.87. Revenue rose to $33K. PAVmed had cash and cash equivalents of $3.8 million as of June 30, 2026, compared to $1.5 million as of December 31, 2025. Mor...
08-14 20:02
PAVmed Q2 Adj. EPS $(0.27) Beats $(0.58) Estimate, Sales $33.000K Miss $72.000K Estimate
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.58) by 53.45 percent. This is a 82 percent increase over losses of $(1.50) per share from the same period last year. The company reported quarterly sales of $33.000 thousand which mis...
08-14 20:01
Lucid Diagnostics (LUCD) 2026财年第二季度业绩电话会议：营收增长17%，Concert保险覆盖取得进展
Lucid Diagnostics 2026财年第二季度业绩电话会议涵盖了150万美元营收、2,770次 EsoGuard 检测、Concert 保险覆盖范围、Medicare 延迟以及3340万美元现金储备。
08-14 08:28
PAVmed Q2 2026 Earnings Preview
PAVmed (PAVM) is scheduled to announce Q2 earnings results on Friday, August 14th, before market open. The consensus EPS Estimate is -$0.63 and the consensus Revenue Estimate is $0.05M Over the last 2...
08-14 02:46
Lucid Diagnostics to Participate in Upcoming Investor Conferences
NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
08-04 20:30
